Questions to bring to a care conversation

“Which medicine are we talking about?”

Get the complete medicine name in writing, along with its form: shot or pill. Is the discussion about cagrilintide alone, CagriSema, or a different drug?

CagriSema brings semaglutide and cagrilintide together as a study treatment.

Semaglutide is a different medicine that copies a body message affecting hunger and blood sugar.

At the September 28, 2026 check, neither cagrilintide nor CagriSema had approval from the FDA, the US drug regulator.

If a study is mentioned, ask: “What is its name and number on ClinicalTrials.gov?”

ClinicalTrials.gov is a free government list of studies; each study has its own number so you can find its record.

Use the study-list link on our sources page to find that record. Ask the study team listed there: “Is this person part of your study?”

A registered trial does not prove that the person offering access is connected to the trial.

“Who is responsible for my care?”

Ask the person treating you for their full name and job: are they a doctor, nurse, or another health worker? Ask for their licence number and the state that gives them permission to practise.

Ask: “Does your licence let you work as a doctor, nurse, or another health worker? Which state board keeps your record?” Check that record, and ask what “specialist” means in their work.

Ask who answers after the first visit and how a follow-up question reaches that person.

“Which parts of my health history matter here?”

Bring the names of your medicines and a short note about your health concerns. Ask which details matter for the treatment being discussed.

If Wegovy (semaglutide) is being discussed, tell the doctor about past illnesses and family health problems.

The official medicine information checked on September 26, 2026 lists health details that matter before prescribing.

Relevant history includes cancer of the thyroid, a gland in the neck, in you or your family.

Pancreas or gallbladder trouble, severe stomach problems, and diabetes-related eye disease also belong in that conversation.

Pregnancy plans, other diabetes medicines, and upcoming surgery also matter when discussing Wegovy.

“What happens if the plan changes?”

Ask how progress is reviewed and new problems are handled. If no medicine is prescribed, ask how the care plan proceeds. Ask when an in-person visit might be needed.

A useful conversation leaves room for your next question, including a question about a different option.